bone and soft tissue sarcomas
Review Article The prognostic value of ezrin expression in bone and soft tissue sarcomas: a meta-analysis
10
Review Article Correlation of ezrin expression level and clinical significance for patients with bone and soft tissue sarcomas: a meta-analysis
11
Development of Multi-disciplinary Approach for Bone and Soft-tissue Sarcomas in Japan
14
Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi institutional retrospective analysis of 134 patients
10
Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis
7
A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas
9
Population-based Aarhus Sarcoma Registry: validity, completeness of registration, and incidence of bone and soft tissue sarcomas in western Denmark
12
The Danish Sarcoma Database
6
Sarcomas in hereditary retinoblastoma
7
Treating metastatic soft-tissue or bone sarcomas – potential role of ridaforolimus
8
UK guidelines for the management of soft tissue sarcomas
26
Analysis of surgical and oncological outcome in internal and external hemipelvectomy in 34 patients above the age of 65 years at a mean follow up of 56 months
9
A Study on Limb Salvage in Extremity Soft Tissue Sarcomas
112
Trabectedin for advanced soft tissue sarcomas: optimizing use
9
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
7
Targeted therapy for soft tissue sarcomas in adolescents and young adults
15
A review of soft-tissue sarcomas: translation of biological advances into treatment measures
26
Expression of heparanase in soft tissue sarcomas of adults
6
MLN-8237: A dual inhibitor of aurora A and B in soft tissue sarcomas
11
New drugs and combinations for the treatment of soft-tissue sarcoma: a review
15